Apply Now

News » Archives » June 2012

Notre Dame researcher’s paper examines the biology and clinical application of tumor-derived microvesicles

Author: William G. Gilroy

A new paper by Crislyn D’Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.

Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment

Author: Arnie Phifer

Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow. One of the difficulties doctors face in treating MM comes from the fact that cancer cells of this type...

International researchers collaborate at Parseghian scientific conference

Author: Marissa Gebhard

Thirty researchers from universities and institutions around the world are presenting at the 2012 Michael, Marcia and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research June 7 to 9 (Thursday to Saturday) in the Jordan Hall of Science at the University of Notre Dame. Niemann-Pick Type C (NPC) disease...

Dovichi receives Royal Society of Chemistry Prize for Analytical Science

Author: Rachel Fellman and Marissa Gebhard

The Royal Society of Chemistry has announced that Norman Dovichi, the Grace-Rupley Professor of Chemistry at the University of Notre Dame, will be awarded the 2012 Robert Boyle Prize for Analytical Science. The biennial prize is given to the candidate whose work is of the broadest relevance to the chemical...